Title:	Application of the comet assay in the evaluation of the semi-synthetic n-butyl dillapiole ether in Balb/C mice.
Authors:	CRUZ, D. L. V. PINTO, A. C. da S. MATOS, L. B. CHAVES, F. C. M. VASCONCELOS, N. S. de GOMES JÚNIOR, P. P. RAFAEL, M. S.
Affiliation:	DANIEL LUÍS VIANA CRUZ, BOLSISTA CPAA; ANA CRISTINA DA SILVA PINTO, BOLSISTA CPAA; LEONARDO BRANDÃO MATOS, INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA; FRANCISCO CELIO MAIA CHAVES, CPAA; NEIVA SILVA DE VASCONCELOS, BOLSISTA CPAA; PLÍNIO PEREIRA GOMES JÚNIOR, FAZENDA SACO; MÍRIAM SILVA RAFAEL, INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA.
Date Issued:	2022
Citation:	In: BRAZILIAN CONGRESS OF GENETICS, 67., 2022, Natal. [Abstracts]. Ribeirão Preto: Sociedade Brasileira de Genética, 2022.
Pages:	p. 476.
Description:	The semi-synthetic n-butyl ether dillapiole (EBD) has a potential effect on the control of Aedes aegypti, the vector of the dengue, Zika, chikungunya, and yellow fever virus. However, there are no studies on the risk of exposure to this compound to the health of humans and other animals. In this sense, the Comet Assay Test is used to detect genomic lesions that can result in mutations. Objective: evaluate the incidence of DNA damage in blood cells of isogenic mice treated with EBD.
NAL Thesaurus:	Vector control Aedes aegypti
Keywords:	Genomic lesions Rodent
Type of Material:	Resumo em anais e proceedings
Access:	openAccess
Appears in Collections:	Resumo em anais de congresso (CPAA)